Single-dose relative bioavailability of a new quetiapine fumarate extended-release formulation: a postprandial, randomized, open-label, two-period crossover study in healthy Uruguayan volunteers.
Phase of Trial: Phase I
Latest Information Update: 15 Jul 2011
At a glance
- Drugs Quetiapine (Primary)
- Indications Bipolar disorders; Schizophrenia
- Focus Pharmacokinetics; Registrational
- 15 Jul 2011 New trial record
- 01 Jun 2011 Results published in the Clinical Therapeutics.